ClinicalTrials.Veeva

Menu

Frequency and Risk Factors for Autoimmune Disorders and Rheumatic Manifestations in Egyptian Patients With IBD

A

Assiut University

Status

Not yet enrolling

Conditions

IBD

Study type

Observational

Funder types

Other

Identifiers

NCT05771363
rheumatology in IBD

Details and patient eligibility

About

To examine the prevelance of autoimmune disorders and rheumatic manifestations in egyptian patients with inflammatory bowel diseases,and asses the relation between prevelance of autoimmune disorders ,rheumatic manifestations and disease activity of IBD

Enrollment

51 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 1-adult patients with adiagnosis of IBD according to the validated criteria. 2-patients>18 years without aprevious diagnosis of SPA or other rheumatological manifestations.

Exclusion criteria

  • 1- patients with active cancer or lymphoproliferative disease. 2-patients with uncontrolled diabetes. 3-patients with unstable ischeamic heart disease or congestive heart failure. 4-patients with acute renal failure. 5-patients already diagnosed with inflammatory or crystal induced arthropathies (including gout and calcium pyrophosphate dehydrate deposition disease) or other autoimmune diseases.

Trial contacts and locations

0

Loading...

Central trial contact

amaal fathi, master

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems